Toner F - Search Results

1

An in vitro skin penetration model for compromised skin: estimating penetration of polyethylene glycol [¹⁴C]-PEG-7 phosphate.

Dey S, Rothe H, Page L, O'Connor R, Farahmand S, Toner F, Marsh R, Wehmeyer K, Zhou S. Dey S, et al. Among authors: toner f. Skin Pharmacol Physiol. 2015;28(1):12-21. doi: 10.1159/000362284. Epub 2014 Jul 15. Skin Pharmacol Physiol. 2015. PMID: 25034576 Free PMC article.

2

Application of in vitro skin penetration measurements to confirm and refine the quantitative skin sensitization risk assessment of methylisothiazolinone.

Rothe H, Ryan CA, Page L, Vinall J, Goebel C, Scheffler H, Toner F, Roper C, Kern PS. Rothe H, et al. Among authors: toner f. Regul Toxicol Pharmacol. 2017 Dec;91:197-207. doi: 10.1016/j.yrtph.2017.10.024. Epub 2017 Nov 6. Regul Toxicol Pharmacol. 2017. PMID: 29080845

3

Optimization of topical formulations using a combination of in vitro methods to quantify the transdermal passive diffusion of drugs.

Hummer J, Birngruber T, Sinner F, Page L, Toner F, Roper CS, Moore DJ, Baker MB, Boncheva Bettex M. Hummer J, et al. Among authors: toner f. Int J Pharm. 2022 May 25;620:121737. doi: 10.1016/j.ijpharm.2022.121737. Epub 2022 Apr 10. Int J Pharm. 2022. PMID: 35413396

4

An OECD TG 428 study ring trial with ¹⁴C-Caffeine demonstrating repeatability and robustness of the dermal absorption in vitro method.

Kluxen FM, Totti S, Maas W, Toner F, Page L, Webbley K, Nagane R, Mingoia R, Whitfield C, Kendrick J, Valentine C, Dorange JB, Egron C, Imart C, Domoradzki JY, Fisher P, Lorez C, McEuen S, Felkers E, Chen T, Wiemann C. Kluxen FM, et al. Among authors: toner f. Regul Toxicol Pharmacol. 2022 Jul;132:105184. doi: 10.1016/j.yrtph.2022.105184. Epub 2022 May 13. Regul Toxicol Pharmacol. 2022. PMID: 35577015 Free article.

5

Support for Regulatory Assessment of Percutaneous Absorption of Retronecine-type Pyrrolizidine Alkaloids through Human Skin.

Plaza A, Toner F, Harris J, Ottersbach P, Roper C, Mahony C. Plaza A, et al. Among authors: toner f. Planta Med. 2022 Feb;88(2):144-151. doi: 10.1055/a-1505-8524. Epub 2021 Jun 11. Planta Med. 2022. PMID: 34116569

6

Corrigendum to "An OECD TG 428 study ring trial with 14C-Caffeine demonstrating repeatability and robustness of the dermal absorption in vitro method" [Regul. Toxicol. Pharmacol. 132 (2022) 105184].

Kluxen FM, Totti S, Maas W, Toner F, Page L, Webbley K, Nagane R, Mingoia R, Whitfield C, Kendrick J, Valentine C, Dorange JB, Egron C, Imart C, Domoradzki JY, Fisher P, Lorez C, McEuen S, Felkers E, Chen T, Wiemann C. Kluxen FM, et al. Among authors: toner f. Regul Toxicol Pharmacol. 2022 Aug;133:105213. doi: 10.1016/j.yrtph.2022.105213. Epub 2022 Jul 8. Regul Toxicol Pharmacol. 2022. PMID: 35811177 Free article. No abstract available.

7

Use of an in vitro human skin permeation assay to assess bioequivalence of two topical cream formulations containing butenafine hydrochloride (1%, w/w).

Mitra A, Kim N, Spark D, Toner F, Craig S, Roper C, Meyer TA. Mitra A, et al. Among authors: toner f. Regul Toxicol Pharmacol. 2016 Dec;82:14-19. doi: 10.1016/j.yrtph.2016.11.008. Epub 2016 Nov 2. Regul Toxicol Pharmacol. 2016. PMID: 27816671

8

Multi-laboratory validation of SkinEthic HCE test method for testing serious eye damage/eye irritation using liquid chemicals.

Alépée N, Leblanc V, Adriaens E, Grandidier MH, Lelièvre D, Meloni M, Nardelli L, Roper CS, Santirocco E, Toner F, Van Rompay A, Vinall J, Cotovio J. Alépée N, et al. Among authors: toner f. Toxicol In Vitro. 2016 Mar;31:43-53. doi: 10.1016/j.tiv.2015.11.012. Epub 2015 Dec 1. Toxicol In Vitro. 2016. PMID: 26612353

9

Multi-laboratory evaluation of SkinEthic HCE test method for testing serious eye damage/eye irritation using solid chemicals and overall performance of the test method with regard to solid and liquid chemicals testing.

Alépée N, Adriaens E, Grandidier MH, Meloni M, Nardelli L, Vinall CJ, Toner F, Roper CS, Van Rompay AR, Leblanc V, Cotovio J. Alépée N, et al. Among authors: toner f. Toxicol In Vitro. 2016 Aug;34:55-70. doi: 10.1016/j.tiv.2016.02.014. Epub 2016 Mar 15. Toxicol In Vitro. 2016. PMID: 26989001

10

Comparison of In Vitro and In Vivo Percutaneous Absorption Across Human Skin Using BAY1003803 Formulated as Ointment and Cream.

Günther C, Kowal K, Schmidt T, Jambrecina A, Toner F, Nave R. Günther C, et al. Among authors: toner f. Clin Pharmacol Drug Dev. 2020 Jul;9(5):582-592. doi: 10.1002/cpdd.736. Epub 2019 Oct 24. Clin Pharmacol Drug Dev. 2020. PMID: 31647607 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page